• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Lundbeck Reveals Bexicaserin`s Positive Long-Term Phase 2 Data

    PR NEWSWIRE

    Lundbeck Presents Bexicaserin Data for Rare Epilepsies at AES

    PHARMIWEB

    Lundbeck`s Bexicaserin Granted Breakthrough Therapy Status

    PR NEWSWIRE

    Lundbeck Presents Amlenetug Phase 3 Mascot Trial Design

    PHARMAWEB

    Lundbeck to Present New Data on Bexicaserin at Upcoming Congress

    PR NEWSWIRE

    Lundbeck gets Orphan drug status in US and EU for Lu AG13909

    PR NEWSWIRE

    Lundbeck`s MSA treatment granted Orphan Drug Designation in Japan

    PR NEWSWIRE

    Tapping into the rare disease market

    BIO PHARMA DIVE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.